Iteos Therapeutics Inc (ITOS)

Jun 17, 2025

iTeos Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025

Jun 17, 2025

Stock Performance Spotlight: ITeos Therapeutics Inc (ITOS) Ends the Day at 10.10, Down by -0.69 - DWinneX

Jun 17, 2025

Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025

Jun 15, 2025

Learn to Evaluate (ITOS) using the Charts - news.stocktradersdaily.com

Jun 15, 2025

Jun 12, 2025

ITeos Therapeutics Insider Sold Shares Worth $1,048,264, According to a Recent SEC Filing - MarketScreener

Jun 12, 2025

Jun 12, 2025

Bank of America Corp DE Decreases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 12, 2025

Jun 11, 2025

Brokerages Set iTeos Therapeutics, Inc. (NASDAQ:ITOS) PT at $15.86 - Defense World

Jun 11, 2025

Jun 09, 2025

ITeos Therapeutics Insider Sold Shares Worth $1,592,520, According to a Recent SEC Filing - marketscreener.com

Jun 09, 2025

Jun 07, 2025

Director David Hallal Sells 114,682 Shares of ITeos Therapeutics Inc (ITOS) - GuruFocus

Jun 07, 2025

Jun 07, 2025

Squarepoint Ops LLC Sells 18,686 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 07, 2025

Jun 06, 2025

iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock By Investing.com - Investing.com India

Jun 06, 2025

Jun 06, 2025

iTeos Therapeutics CEO Michel Detheux sells $1.59m in stock - Investing.com

Jun 06, 2025

Jun 06, 2025

iTeos Therapeutics Executives Sell Significant Shares - TradingView

Jun 06, 2025

Jun 06, 2025

Nuveen Asset Management LLC Trims Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 06, 2025

Jun 05, 2025

iteos therapeutics announces board resignation - Investing.com

Jun 05, 2025

Jun 05, 2025

iteos therapeutics announces board resignation By Investing.com - Investing.com UK

Jun 05, 2025

Jun 05, 2025

Tim Van Hauwermeiren Resigns from iTeos Board - TipRanks

Jun 05, 2025

Jun 04, 2025

Deutsche Bank AG Sells 14,418 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jun 04, 2025

Jun 03, 2025

More bad news in biotech: Watertown cancer firm iTeos shutting down - The Boston Globe

Jun 03, 2025

Jun 02, 2025

Long Term Trading Analysis for (ITOS) - news.stocktradersdaily.com

Jun 02, 2025

Jun 02, 2025

Q2 EPS Forecast for iTeos Therapeutics Decreased by Analyst - Defense World

Jun 02, 2025

Jun 01, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Position Increased by Ameriprise Financial Inc. - Defense World

Jun 01, 2025

May 31, 2025

iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know - MSN

May 31, 2025

May 31, 2025

Wedbush Lowers Earnings Estimates for iTeos Therapeutics - Defense World

May 31, 2025

May 30, 2025

Rx Rundown: Novartis, iTeos Therapeutics, Moderna and more - Medical Marketing and Media

May 30, 2025

May 30, 2025

iTeos Therapeutics Stock Jumps Following Operational Closure Announcement - MSN

May 30, 2025

May 29, 2025

All Over For iTeos But Applause For Plan To Return Cash Fast - insights.citeline.com

May 29, 2025

May 29, 2025

iTeos to shut down operations after TIGIT setback and GSK exit - The Pharma Letter

May 29, 2025

May 29, 2025

iTeos Therapeutics (NASDAQ:ITOS) Receives “Equal Weight” Rating from Wells Fargo & Company - Defense World

May 29, 2025

May 29, 2025

iTeos Therapeutics to wind down operations, explore asset sales By Investing.com - Investing.com South Africa

May 29, 2025

May 29, 2025

iTeos Therapeutics (NASDAQ:ITOS) Lowered to “Neutral” Rating by Wedbush - Defense World

May 29, 2025

May 28, 2025

Wedbush cuts iTeos stock rating, raises PT to $12 from $10 - Investing.com Canada

May 28, 2025

May 28, 2025

Drug developer iTeos to shut down operations after cancer therapy setback - 1470 & 100.3 WMBD

May 28, 2025

May 28, 2025

Cancer drugmaker iTeos to shut down - BioPharma Dive

May 28, 2025

May 28, 2025

iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’ - Investing.com India

May 28, 2025

May 28, 2025

iTeos Therapeutics stock surges on wind-down news By Investing.com - Investing.com Canada

May 28, 2025

May 28, 2025

Watertown immuno-oncology biotech winds down operations - The Business Journals

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) Downgraded by Wells Fargo with Revised Price Target | ITOS Stock News - GuruFocus

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) Faces Downgrade Amid Operational Changes | ITOS Stock News - GuruFocus

May 28, 2025

May 28, 2025

ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | - GuruFocus

May 28, 2025

May 28, 2025

ITeos Therapeutics (ITOS) Sees Downgrade and Target Price Cut | ITOS Stock News - GuruFocus

May 28, 2025

May 28, 2025

iTeos Therapeutics stock surges on wind-down news - Investing.com

May 28, 2025

May 28, 2025

ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbus - GuruFocus

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) Downgraded as Company Plans Operationa - GuruFocus

May 28, 2025

May 28, 2025

Wedbush Downgrades iTeos Therapeutics (ITOS) Rating to Neutral | - GuruFocus

May 28, 2025

May 28, 2025

I Teos Therapeutics Inc Expected Severance Costs Of $21.8 Million To $24.7 Million - marketscreener.com

May 28, 2025

May 28, 2025

ITeos Therapeutics (ITOS) Receives Analyst Downgrade from Wedbush | ITOS Stock News - GuruFocus

May 28, 2025

May 28, 2025

Wedbush Downgrades iTeos Therapeutics to Neutral From Outperform, Adjusts Price Target to $12 From $10 - marketscreener.com

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) to Cease Operations and Explore Strate - GuruFocus

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) Shares Surge on Plans to Cease Operati - GuruFocus

May 28, 2025

May 28, 2025

iTeos Therapeutics (ITOS) to Wind Down Operations, Focus on Shar - GuruFocus

May 28, 2025

May 28, 2025

Drug developer iTeos winds down after cancer therapy setback - marketscreener.com

May 28, 2025